Follistatin
Latest Information Update: 02 Oct 2021
At a glance
- Originator Network Limited
- Class Carrier proteins; Glycoproteins
- Mechanism of Action Tissue replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Kidney disorders; Liver disorders
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Kidney-disorders in Australia
- 04 Nov 2017 No recent reports of development identified for preclinical development in Liver-disorders in Australia
- 26 Apr 2007 Preclinical development is ongoing